Astria Therapeutics's total assets for Q2 2025 were $281.92M, a decrease of -9.17% from the previous quarter. ATXS total liabilities were $21.41M for the fiscal quarter, a 1.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.